Analysis of Domestic Veterinary Drug Raw Materials Market in The 46th Week of 2021
Cephalosporins and Penicillins
The prices of ceftiofur Sodium and ceftiofur hydrochloride fluctuated slightly. Since last year, many companies have been put into production one after another. The market supply is relatively sufficient, and the prices of different manufacturers have large differences. The price increase in the past year has not been large. Ceftiofur Hydrochloride 1820, Ceftiofur Sodium 2320
Cefquinome Sulfate, the price fluctuates, the market supply and demand balance, the quotation is below 8000
Amoxicillin, the price has risen and stopped rising, the ups and downs of the price have recently stabilized and wait-and-see status, the quotation is more than 200, and the transaction price varies greatly due to regional reasons.
Amoxicillin sodium, an upward trend Market price 568
Potassium amoxicillin and clavulanate, on the strong side, current storage conditions are relatively suitable, and trading is strong
Ampicillin, Ampicillin Sodium, Strong, Ampicillin Market Price 227, Ampicillin Sodium 287
Penicillin sodium (potassium), whose price fluctuated at the top of the market, fluctuated at a high level, and terminal on-demand purchases were active, and the transaction volume surged. Penicillin sodium was quoted at 320, penicillin potassium industrial salt was quoted at more than 110, and the price at the same period last year was 80, a huge shock. In 2019 The price is 66 in the same period, and the overall trend is going up year by year
Aminoglycosides
Kanamycin monosulfate has recently fallen back in volatility, and the market price is 297-310. The price of this product will always remain within 300 in 2019 and 2020. This year, the price is outstanding and the price is running at a high level.
Neomycin sulfate, affected by the various parties in the market, the price has risen in an orderly manner. The quotation is 152-158. The market inquiries are active. The supply of upstream manufacturers is balanced. The market quotation is promoted in an orderly manner. The increase is still controllable. The price remained at the third quarter. In the range of 137-145, the market competition has been fierce in recent years. The overall operation of neomycin sulfate this year is relatively low-key, and the price trend is cautious. Under the "dual control of energy consumption" policy, the price increase is relatively large. The Asia-Pacific Data Analysis Center focuses on
Spectinomycin hydrochloride, the price jumped, the recent surge in inquiries, manufacturers stopped reporting, in recent years this product has not shown sharpness, low-key operation, dual energy consumption and other policy influences, price adjustments, the market price is above 595
Gentamicin sulfate, the price rose slightly, the market is not very enthusiastic, continue to pay attention to the later trend
Streptomycin sulfate, the ex-factory price is raised, the market is low-priced and the supply is less, the trading volume is strong, and the transaction price is strong 265-295
Apramycin sulfate, various factors drove active inquiries, increased market attention, and stable market quotations
Tetracycline and Chloramphenicol
Doxycycline hydrochloride has returned to high levels rationally, the price is at a turning point, the supply of goods is relatively balanced, the price is falling, and the market quotation is below 700
Oxytetracycline and oxytetracycline hydrochloride are operating on the strong side, some manufacturers are short of supply, and market inquiries and concerns have increased. The transaction price of oxytetracycline is 83-87. Oxytetracycline hydrochloride market price 105-115
Chlortetracycline hydrochloride, a slight upward trend, the market price is 228
Florfenicol, recent hot products have repeatedly set new highs, and active inquiries have turned to cautious wait-and-see. The exciting price is beyond the range of rational acceptance, and the price still has room to fall. The market quotation is below 700. Asia-Pacific Data Analysis Center focuses on products
Macrolides
The price of erythromycin thiocyanate rose, and the transaction price was stable at 370-395. The price of the same period in 2020 was 330, an increase of 12.7%. The price of the same period in 2019 was 320. In recent years, the price at its peak was 465 in the same period of 2018.
Tylosin tartrate fluctuated in the early stage, and the current quotation has stabilized. Entering October, affected by the policy of dual control of energy consumption, the price increased greatly, and the market quotation exceeded 310. Tylosin is an intermediate of many products, and its price changes have caused a chain reaction. A month-on-month increase of 8.7%, a year-on-year increase of 40.4%, the price in the same period in 2020 is 235, the price in the same period in 2019 is 220, and the price in the same period in 2018 is 405
Lincomycin hydrochloride has been operating smoothly, and the policy impact has not yet appeared. Compared with other products, the price differentiation is obvious. The transaction price ranged from 332 to 345. The price was strong in the first half of the year. In the second half of the year, affected by the market, the price was slightly weak. Prices continue to fall, and the recent decline has stopped steadily
The price of colistin sulfate continues at a high level. The market price is around 117. It is a bulk product with a large terminal consumption and active market transactions. Each price increase has a significant impact on the market. The current price market has generally accepted it. The price of the same period in 2020 is 104, 2019 The price of the same period is 95, and the price of the same period of 2018 is 100;
Tiamulin fumarate is operating at a high level, the supply is tight, the increase rate has narrowed, the market response is dull and rational, and the transaction volume has not increased significantly. The current price is 295-315. The average price in January was 262, rose to 320 in February, 346 in March, 325 in April, and 308 in May. The price continued to fall in June, reaching a low of 260. In July, it began to strengthen at 275. In August, the price rose to 298. In September The price is around 300. Under the dual-control policy in October, we are singing all the way
Tyvanin tartrate, fluctuating at a high level, sufficient upstream supply, weakened downstream demand, and a large gap in market quotation, the transaction price was 750-795, the market transaction price was 625 in mid-December last year, and the supply began to tighten in the second half of the year, and the price rose straightly and continued. By the end of March this year, the supply of goods has been eased. After April, the supply of goods has increased. The transaction price in May was 800-826. In June, the price fluctuated at a high level. The price declined in July. The price has remained stable since August.
Tilmicosin and Tilmicosin phosphate have a large price increase, which has aroused strong market response. The market is mostly holding a wait-and-see attitude. Inquiries have increased, and the transaction volume is small. The current quotation of Tilmicosin is gradually clearer than 469, 2020. The price of the same period was 338, and the price of the same period of 2019 was 331. Tilmicosin phosphate market offers a wide range of 425-445, an increase of 10.5% month-on-month. The price for the same period in 2020 is 335, an increase of 29.2% year-on-year
Sulfonamides and Quinolones
Sulfonamide products fluctuated and adjusted in the short-term, the market reaction was stable, and the terminal demand was weak. Under the tightness of raw materials and the dual control policy, manufacturers adjusted cost prices in a timely manner, and the current trend is stable; Asia-Pacific Yihe Data Analysis Center focuses on products
Sulfadiazine (sodium), the price is strong, due to the dual control policy to limit production and electricity, the quotation increased to 266, the price of 240 in the same period last year; the price of 285 in the same period in 2019;
Sulfamethazine (sodium), the transaction price goes up, the market price is 120
Sulfamethoxazole (sodium), the price has increased greatly
Sulfonamide versus methoxypyrimidine (sodium), strong operation and active trading
Sulfamonomethoxine (sodium) has a high source of supply. Affected by various factors such as raw material intermediates, the source of supply is more in short supply. The market quotation is above 355, the overall performance this year is strong, and the upstream supply is insufficient, which cannot fully meet the market demand
Sulfachloropyrazine sodium, the price rose, the transaction price was 376, the price of the same period last year was basically the same in the range of 365-370, the price of the same period in 2019 was 385, and the price of the same period in 218 was 240, the lowest value in recent years;
Sulfachlordazine sodium, the market is stable and the price is high, the market price is 339, an increase of 14.2% year-on-year
Sulfaquinoxaline Sodium, the price is rising, the market price is 390
Trimethoprim and trimethoprim lactate have increased significantly. In recent years, the price of this product has been relatively stable, with balanced supply and demand, without major fluctuations. Recently, it has also fluctuated up with the market direction. Some areas of trimethoprim lactate are as high as 190 or more. , The price of 179 in the same period last year; the market quotation of trimethoprim increased to more than 260, 235 in the same period last year, an increase of 10.6%
Ditrimethoprim (DVD), market price 390
Prices of quinolone products continued to rebound, manufacturers stopped reporting and signing, and market transactions were active. Constrained by the "dual control of energy consumption", power and production restrictions, manufacturers' supply continues to be tight, market stocks have almost been consumed, and the spot market has entered a tight cycle. Manufacturers have continuously increased their ex-factory prices from September to now.
Enrofloxacin and Enrofloxacin Hydrochloride have strong prices and strong performance. Low-priced inventory has decreased. The market price is around 260, and the price in the same period last year was 205, a year-on-year increase of 26.8% and a month-on-month increase of 6.6%.
The prices of ciprofloxacin lactate and ciprofloxacin hydrochloride have gone up, and the market quotation is above 230, an increase of 23.8% year-on-year. The price in the same period in 2020 is 206; the price in the same period in 2019 is 195;
Sarafloxacin hydrochloride, the price goes up
Marbofloxacin, price strength
Antiparasitic
Diclazuril, the price goes up, the supply is tight, the market price is 1590
The price of albendazole led the increase. Affected by the increase in raw materials, manufacturers increased their shipment prices, and delivery was tight. The market quoted price was over 180, slightly higher than the price of the same period last year. The price of the same period in 2020 was 165, and the price of the same period in 2019 was 249, June. The highest price rose to 276, a historical high. The tight supply continued until July 2020. The price began to fall and fell to less than 200 in August. In the first half of 2021, the overall stability is accompanied by slight fluctuations. In the third quarter, it is hovering in the range of 147-157. Entering October, the price opens an upward channel.
Fenbendazole, the price goes up, the market transaction is weak, the price is 349
Abamectin, strong operation, small trading volume, market price 825
The price of Ivermectin is rising, and the market price is above 1500. The price of this product has remained at around 1250-1400 from 2019 to 2020. There was a slight fluctuation in the first half of this year, but the amplitude was not large. In the third quarter, due to the increase in raw materials, the policy Sexual tightening and other factors, prices are rising
Toczuril, the price goes up, the volatility is intensified, and the market price is around 1500
Levamisole hydrochloride, the price is rising, the supply is tight, the market price is about 488, because the original purchase cost has increased too fast, the upstream production supply is tight, and the market supply is less
Metronidazole, the price goes up, the market price is 87
Dimenidazole, high and strong operation, slow release of upstream sources, slightly tight supply, market quotation is above 120
Praziquantel, the price is rising, the market price is 598
Antipyretic, analgesic, antiasthmatic, improve immunity
Flunixin meglumine, running at high level, weak demand, market price 950-990
Analgin's price increase is unexpected. The upstream supply is sufficient, and the downstream is slightly weak. The price is around 90. The price of the same period in 2020 is 70, a year-on-year increase of 20%, and the price of the same period in 2019 is 65. Analgin started its upward channel at the end of last year. This year, the overall price has shown an upward pattern. The price in January was 78, and the price fell slightly in March. It maintained stability in April and continued to exert its strength in May. As of now, the market price is above 90.
Acetaminophen, both volume and price rise, running at a high level, the market quotation is above 60, a year-on-year increase of 48.8%
Carbopirin calcium, price upside is unstoppable, quotation 44-49
Taurine, the price goes up, the upward trend is obvious, the transaction price is about 25
Veterinary medicine excipients and other categories
Sodium salicylate, fluctuates upwards, the market price is above 30
Sodium citrate, strong trend
Sodium camphor sulfonate, stable situation, low price
Acephine, with strong demand, prices rise again, market quotation 65-70
Chlorpheniramine, the price is stable and high, the market quotation is above 260, the price of the same period last year is 160
Glucose, the transaction is stable, the tonnage price range is 5850~6800
Jiayi powder, starch, stable transaction
Beta cyclodextrin, stable market quotation 26, a year-on-year increase of 23.4%
Vitamins
VA, steadily rising, quotation for mixing 326, water soluble 336
VB1, the quotation is strong and the quotation is increased, nitric acid 195, hydrochloric acid 282
VB2, recent strong operation, market quotation 80% 107, 98% 356
VB6, the market price rises, some manufacturers stop reporting, the price is about 194
VB12, price consolidation, market quotation 152-158
VC, stopped falling and rose slightly, the supply is tight, the current price is around 46
VD3, manufacturers increase the upward channel, the quotation is raised, the mixing material is 130, the water solubility is 142
VE, rising steadily, mixing 95, water soluble 114
VK3, raw materials are tight, prices continue to rise, market quotations rise 205-229
Calcium pantothenate, the supply is less, the price increases, the market transaction goes up, the market price is 115
Niacinamide, running smoothly, currently quoted at 56
2% biotin, the price increase is large, the market price is 97
Folic acid, under the dual control policy, the price rises, the quotation is about 382
Looking for chemical products? Let suppliers reach out to you!
New progress for oral covid drug
2026-07-13
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab
-
Personalized supplements startup VitaminLab raises series A financing
-
Overview of China's API industry in 2023
-
Global Analysis of Active Pharmaceutical Ingredient (API)
-
Professional and technical dry goods: a brief discussion on the selection of starting materials for chemical synthesis APIs
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
Vitamin Market Analysis
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
In 2021, India's Ibuprofen API Export Volume and Price will Fall
-
Corning Cooperative API Plant Puts into Operation
Recommend Reading
-
A Faster Route to Diabetes Drug Chemistry
-
FDA Warning Letters Put GMP Back in Focus
-
India Targets Fake Drug Packaging
-
India’s Pharma Cost Problem Gets Worse
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
Carrot Extract Gets EU Novel Food Approval
-
Premium Global Chemical Sourcing Requests (2-3Jun, 2026)
-
POND GROUP Acquires All Grace, Boosting Cosmetics Market Share by 20%
-
Uses of Sodium Acetate Trihydrate
-
EU Clears a New Gut Health Ingredient